Global Blue Group Holding AG(GB)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $7.28 – $7.50
- IV Rank (30D)
- 7.45
- Straddle Price
- $2.45
- P/C Vol Ratio
- 1.00
- Market Cap
- $1.5B
- Exchange
- XNYS
- Market Cap
- $1.5B
Global Blue Group Holding AG offers a seamless shopping and payment journey for tourists and also provides a wide range of Added-Value Payment Solutions for all the stakeholders involved, including retailers and international shoppers. The group offers third-party serviced Tax Free Shopping (TFS), Payments, which include dynamic currency conversion (DCC), and Post-Purchase Solutions (PPS). Its geographical segments include Europe, Asia, and Rest of the World.
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +6.33% | 5 |
| Feb | +3.59% | 5 |
| Mar | -5.06% | 5 |
| Apr | -6.36% | 5 |
| May | -6.19% | 5 |
| Jun | -0.42% | 5 |
| Jul | -3.14% | 5 |
| Aug | +4.29% | 5 |
| Sep | +0.38% | 4 |
| Oct | -3.96% | 4 |
| Nov | +1.01% | 4 |
| Dec | +0.21% | 4 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
- IV Rank (30D)
- 7.45
- IV Rank (7D)
- 7.45
- Avg IV
- 104.4%
- Straddle (30D)
- $2.45
- Straddle (7D)
- $2.45
- P/C Volume
- 1.00
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- 0.10
- Correlation (SPY)
- 16.4%
- R²
- 0.03
- Ann. Volatility
- 6.1%
- SPY Volatility
- 10.0%
Low volatility - stock moves less than market
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2016-03-10 | THOMAS J HOOK | President & CEO | Award (A) | — | — | EDGAR | |
| 2016-01-25 | MICHAEL DINKINS | Exe VP Chief Financial Officer | Mixed | +21,262 | $41.45 | -$392.0K | EDGAR |
| 2016-01-25 | Andrew P Holman | EVP, Global Sales & Marketing | Mixed | +5,401 | $41.45 | -$86.1K | EDGAR |
| 2016-01-19 | THOMAS J MAZZA | VP, Corporate Controller | Mixed | +5,109 | $41.45 | -$131.1K | EDGAR |
| 2016-01-19 | Andrew P Holman | EVP, Global Sales & Marketing | Mixed | +4,681 | $41.45 | -$116.0K | EDGAR |
| 2016-01-19 | MICHAEL DINKINS | Exe VP Chief Financial Officer | Mixed | +22,225 | $41.45 | -$352.1K | EDGAR |
| 2016-01-19 | Mauricio Arellano | EVP, Global Operations | Mixed | +15,677 | $41.45 | -$491.8K | EDGAR |
| 2016-01-19 | Timothy G McEvoy | Sr. VP, Gen. Counsel & Sec. | Mixed | +5,824 | $41.45 | -$148.5K | EDGAR |
| 2016-01-19 | Jose Antonio Gonzalez | President, CRM & Neuro | Mixed | +2,505 | $41.45 | -$66.2K | EDGAR |
| 2016-01-19 | Jennifer M Bolt | President, Electrochem | Mixed | +3,674 | $41.45 | -$76.9K | EDGAR |
| 2016-01-19 | THOMAS J HOOK | President & CEO | Mixed | +43,530 | $41.45 | -$1.41M | EDGAR |
| 2016-01-11 | Declan Smyth | Pres., Advanced Surgical, Orth | Award (A) | +2,575 | — | EDGAR | |
| 2016-01-06 | BILL R SANFORD | Director | Award (A) | +2,744 | — | EDGAR | |
| 2016-01-05 | Kristin Trecker | Chief Human Resource Officer | Grant (A) | +10,450 opt | — | EDGAR | |
| 2016-01-05 | MICHAEL DINKINS | Exe VP Chief Financial Officer | Award (A) | — | — | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | EDWARD F VOBORIL | Director | 211,403 | $1.58M | $0 | 5 | 2008-01-02 |
| 2 | THOMAS J HOOK | President & CEO | 202,384 | $1.52M | -$2.43M | 41 | 2016-03-10 |
| 3 | Susan M Bratton | EVP, Business Development | 62,892 | $471.1K | -$662.2K | 27 | 2013-06-12 |
| 4 | BILL R SANFORD | Director | 54,522 | $408.4K | -$600.5K | 12 | 2016-01-06 |
| 5 | Mauricio Arellano | EVP, Global Operations | 54,078 | $405.0K | -$3.02M | 38 | 2016-01-19 |
| 6 | LARRY T DEANGELO | Sr.VP, Administration and Secr | 46,928 | $351.5K | $0 | 1 | 2007-01-03 |
| 7 | MICHAEL DINKINS | Exe VP Chief Financial Officer | 40,269 | $301.6K | -$614.4K | 15 | 2016-01-25 |
| 8 | WILLIAM B JR SUMMERS | Director | 38,215 | $286.2K | -$108.3K | 13 | 2016-01-05 |
| 9 | PAMELA G BAILEY | Director | 33,203 | $248.7K | $0 | 14 | 2016-01-05 |
| 10 | Timothy G McEvoy | Sr. VP, Gen. Counsel & Sec. | 31,009 | $232.3K | -$427.3K | 24 | 2016-01-19 |
| 11 | PETER H SODERBERG | Director | 30,388 | $227.6K | $0 | 14 | 2016-01-05 |
| 12 | JOSEPH A MILLER | Director | 25,622 | $191.9K | -$114.3K | 15 | 2016-01-05 |
| 13 | Michelle Graham | Sr. VP Human Resources | 24,723 | $185.2K | -$16.1K | 10 | 2014-08-11 |
| 14 | THOMAS J MAZZA | VP, Corporate Controller | 24,563 | $184.0K | -$3.05M | 32 | 2016-01-19 |
| 15 | Richard M. Farrell | VP, QIG Group | 21,423 | $160.5K | $0 | 4 | 2010-01-05 |
| 16 | KEVIN C MELIA | Director | 21,353 | $159.9K | $61.2K | 9 | 2014-01-06 |
| 17 | Susan H Campbell | Sr. VP, Orthopaedics | 18,053 | $135.2K | $0 | 9 | 2010-03-12 |
| 18 | Jennifer M Bolt | President, Electrochem | 15,028 | $112.6K | -$169.7K | 4 | 2016-01-19 |
| 19 | John Ayliffe | VP Europe | 13,727 | $102.8K | $207.9K | 3 | 2008-09-12 |
| 20 | Barbara M Davis | Vice President, Human Resource | 13,436 | $100.6K | -$4.8K | 7 | 2010-01-05 |
| 21 | JOHN P WAREHAM | Director | 12,490 | $93.6K | $0 | 5 | 2010-01-05 |
| 22 | Anthony P III Bihl | Director | 11,727 | $87.8K | $0 | 6 | 2016-01-05 |
| 23 | John T. Farrell | VP, Therapy Delivery | 11,290 | $84.6K | $0 | 2 | 2008-03-05 |
| 24 | Andrew P Holman | EVP, Global Sales & Marketing | 10,905 | $81.7K | $0 | 7 | 2016-01-25 |
| 25 | Helena S. Wisniewski | Director | 9,610 | $72.0K | -$74.0K | 7 | 2012-01-04 |
| 26 | THOMAS S SUMMER | Director | 8,559 | $64.1K | -$22.5K | 5 | 2008-05-29 |
| 27 | Joseph W Dziedzic | Director | 7,627 | $57.1K | $0 | 4 | 2016-01-05 |
| 28 | Jose Antonio Gonzalez | President, CRM & Neuro | 7,312 | $54.8K | $0 | 3 | 2016-01-19 |
| 29 | George M Cintra | Exec. VP, CTO | 6,989 | $52.3K | $0 | 4 | 2015-01-21 |
| 30 | Marco Benedetti | Corp Contr & Treasurer | 6,167 | $46.2K | $0 | 13 | 2012-03-06 |
| 31 | Rudy A Mazzocchi | Director | 4,904 | $36.7K | $0 | 3 | 2014-01-06 |
| 32 | Patrick Berdoz | Sr. VP Orthopedics | 4,419 | $33.1K | $0 | 1 | 2008-03-05 |
| 33 | Declan Smyth | Pres., Advanced Surgical, Orth | 2,757 | $20.6K | $0 | 2 | 2016-01-11 |
| 34 | MARTIN C MAXWELL | Director | 2,718 | $20.4K | $0 | 2 | 2016-01-05 |
| 35 | FILIPPO PASSERINI | Director | 2,718 | $20.4K | $0 | 2 | 2016-01-05 |
| 36 | Jean M. Hobby | Director | 2,718 | $20.4K | $0 | 2 | 2016-01-05 |
| 37 | Marcia A Dall | Director | 2,157 | $16.2K | $51.6K | 2 | 2015-05-07 |
| 38 | Daniel Robert Kaiser | Chief Technology Officer | 336 | $2.5K | $0 | 2 | 2013-01-03 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.